EMCREG-International
  • Home
  • MEMBERS
  • EMCREG On The Go MONOGRAPHS Stroke Journey ALGORITHMS SYMPOSIA
  • CME
  • EXPERTISE
  • Contact
  • About
  • SEARCH
  • SUBSCRIBE

EMCREG-International

  • Home/
  • MEMBERS/
  • EDUCATION/
    • EMCREG On The Go
    • MONOGRAPHS
    • Stroke Journey
    • ALGORITHMS
    • SYMPOSIA
  • CME/
  • EXPERTISE/
  • Contact/
  • About/
  • SEARCH/
  • SUBSCRIBE/
EMCREG+banner+logo+final.png

EMCREG-International

COLLABORATE | INVESTIGATE | EDUCATE

ACEP2019

EMCREG-International

  • Home/
  • MEMBERS/
  • EDUCATION/
    • EMCREG On The Go
    • MONOGRAPHS
    • Stroke Journey
    • ALGORITHMS
    • SYMPOSIA
  • CME/
  • EXPERTISE/
  • Contact/
  • About/
  • SEARCH/
  • SUBSCRIBE/
March 25, 2020

Use of Oral Anticoagulants: Coumadin, Factor IIa, and Factor Xa

March 25, 2020/ EMCREG-International
Use of Oral Anticoagulants: Coumadin, Factor IIa, and Factor Xa

Use of Oral Anticoagulants: Coumadin, Factor IIa, and Factor Xa

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Treatment of Severe Bleeding in the ED: 4 Factor PCCs, Idarucizumab, and Andexanet Alfa

March 25, 2020/ EMCREG-International
Treatment of Severe Bleeding in the ED: 4 Factor PCCs, Idarucizumab, and Andexanet Alfa

Treatment of Severe Bleeding in the ED: 4 Factor PCCs, Idarucizumab, and Andexanet Alfa

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

ANNEXA-4 Trial: Full Study Report and Considerations for Treatment of Major Hemorrhage

March 25, 2020/ EMCREG-International
ANNEXA-4 Trial: Full Study Report and Considerations for Treatment of Major Hemorrhage

ANNEXA-4 Trial: Full Study Report and Considerations for Treatment of Major Hemorrhage

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Development of an ED-based Severe Bleeding Treatment Algorithm for Anticoagulated Patients

March 25, 2020/ EMCREG-International
Development of an ED-based Severe Bleeding Treatment Algorithm for Anticoagulated Patients

Development of an ED-based Severe Bleeding Treatment Algorithm for Anticoagulated Patients

Read More
March 25, 2020/ EMCREG-International/
March 25, 2020

Optimal Prehospital Care for the Exsanguinating Anticoagulated Patient

March 25, 2020/ EMCREG-International
Optimal Prehospital Care for the Exsanguinating Anticoagulated Patient

Optimal Prehospital Care for the Exsanguinating Anticoagulated Patient

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Role of the Hospitalist in Treating Severe Bleeding for Anticoagulated Patients

March 25, 2020/ EMCREG-International
Role of the Hospitalist in Treating Severe Bleeding for Anticoagulated Patients

Role of the Hospitalist in Treating Severe Bleeding for Anticoagulated Patients

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Caring for the Anticoagulated Trauma Victim and Those Requiring Emergent Surgery

March 25, 2020/ EMCREG-International
Caring for the Anticoagulated Trauma Victim and Those Requiring Emergent Surgery

Caring for the Anticoagulated Trauma Victim and Those Requiring Emergent Surgery

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Upper Gastrointestinal & Mucosal Bleeding: When Do You Use Reversal Agents?

March 25, 2020/ EMCREG-International
Upper Gastrointestinal & Mucosal Bleeding: When Do You Use Reversal Agents?

Upper Gastrointestinal & Mucosal Bleeding: When Do You Use Reversal Agents?

Read More
March 25, 2020/ EMCREG-International/
acep2019
severe bleeding
March 25, 2020

Intracranial Bleeding Catastrophes and Safely Performing Procedures in the Anticoagulated Neurocritical Care Patient

March 25, 2020/ EMCREG-International
Intracranial Bleeding Catastrophes and Safely Performing Procedures in the Anticoagulated Neurocritical Care Patient

Intracranial Bleeding Catastrophes and Safely Performing Procedures in the Anticoagulated Neurocritical Care Patient

Read More
March 25, 2020/ EMCREG-International/
  • Home/
  • MEMBERS/
  • EDUCATION/
    • EMCREG On The Go
    • MONOGRAPHS
    • Stroke Journey
    • ALGORITHMS
    • SYMPOSIA
  • CME/
  • EXPERTISE/
  • Contact/
  • About/
  • SEARCH/
  • SUBSCRIBE/

EMCREG-International

Subscribe for complimentary material and announcements.

SUBSCRIBE

Featured
Optimal Management of The Anticoagulated Patient With Life-Threatening Bleeding In The Emergency Department And Intensive Care Unit: A Case-Based Approach
January 21, 2020
Optimal Management of The Anticoagulated Patient With Life-Threatening Bleeding In The Emergency Department And Intensive Care Unit: A Case-Based Approach
January 21, 2020

For acute care physicians , the current approach and disease indications for treatment with anticoagulants are particularly relevant. When a patient treated with anticoagulants presents to the emergency department, intensive care unit, or operating room with severe, uncontrolled bleeding, the achievement of rapid controlled hemostasis is extremely important to saving the patient’s life.

Read more →
January 21, 2020
A Case-based Approach to Treatment of Life-Threatening Bleeding in the Anticoagulated Patient in the ED
September 1, 2019
A Case-based Approach to Treatment of Life-Threatening Bleeding in the Anticoagulated Patient in the ED
September 1, 2019

Detailed discussion regarding the current treatment of critically-ill or critically-injured patients with life-threatening bleeding that present to the ED or critical care unit.

Read more →
September 1, 2019
Management of Life-Threatening Bleeding In The Anticoagulated Patient In The Emergency Setting And The Impact of ANNEXA-4 On The Treatment of Patients Taking Factor Xa Inhibitors
August 13, 2019
Management of Life-Threatening Bleeding In The Anticoagulated Patient In The Emergency Setting And The Impact of ANNEXA-4 On The Treatment of Patients Taking Factor Xa Inhibitors
August 13, 2019

Management of severe bleeding in patients taking oral anticoagulants is complicated. Acute care physicians must be knowledgeable about the individual oral anticoagulant agents, the general management of anticoagulant-associated bleeding, and the strategies for effective use of factor repletion and specific reversal agents.

Read more →
August 13, 2019
Hyperkalemia: Advancing Care In The Emergency Department And Intensive Care Unit
February 8, 2019
Hyperkalemia: Advancing Care In The Emergency Department And Intensive Care Unit
February 8, 2019

Expert specialists from Emergency Cardiovascular and Neurovascular Care, Pre-hospital Emergency Medical Services, Emergency Medicine Operations, Nephrology, Hospital Medicine, Neurocritical Care, Cardiology, Medical Critical Care, and Trauma and Surgical Critical Care discuss the implications of managing hyperkalemia in their field with patients in the Emergency Department, Critical Care Units, and the Cardiology Clinic.

Read more →
February 8, 2019
Management of Severe Bleeding In Patients Treated With Oral Anticoagulants
December 26, 2018
Management of Severe Bleeding In Patients Treated With Oral Anticoagulants
December 26, 2018

For emergency physicians, critical care physicians, hospitalists, cardiologists, internists, surgeons, and family physicians, the current approach and disease indications for treatment with anticoagulants such as coumadin, Factor IIa, and Factor Xa inhibitors are particularly relevant. When a patient treated with anticoagulants presents to the Emergency Department, Intensive Care Unit, or Operating Room with severe, uncontrollable bleeding, achieving rapid, controlled hemostasis is critically important to saving the patient’s life.

Read more →
December 26, 2018

COLLABORATE | INVESTIGATE | EDUCATE


Copyright © EMCREG-International